1-10 of 10
Doris Siwak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1353: The clinical utility of ctDNA in colorectal cancer validated by multiregional sequencing and protein analysis

Mizunori Yaegashi, Takeshi Iwaya, Masashi Fujita, Zhenlin Ju, Doris Siwak, Kei Sato, Fumitaka Endo, Ryo Sugimoto, Tamotsu Sugai, Lance Liotta, Yiling Lu, Gordon Mills, Hidewaki Nakagawa, Satoshi Nishizuka
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1353.
https://doi.org/10.1158/1538-7445.AM2019-1353
Published: 01 July 2019
View article titled, Abstract 1353: The clinical utility of ctDNA in colorectal cancer validated by multiregional sequencing and protein analysis
Journal Articles

Abstract 2229: Molecular profile of histological and mutational heterogeneity of adenocarcinoma of the stomach in tumor burden monitoring using circulating tumor DNA

Noriyuki Sasaki, Takeshi Iwaya, Takehiro Chiba, Masashi Fujita, Fumitaka Endo, Mizunori Yaegashi, Ryo Sugimoto, Tamotsu Sugai, Doris Siwak, Lance Liotta, Yilling Lu, Gordon Mills, Hidewaki Nakagawa, Satashi S. Nishizuka
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2229.
https://doi.org/10.1158/1538-7445.AM2019-2229
Published: 01 July 2019
View article titled, Abstract 2229: Molecular profile of histological and mutational heterogeneity of adenocarcinoma of the stomach in tumor burden monitoring using circulating tumor DNA
Journal Articles

Abstract 4646: Evaluation of EGFR gene amplification status, mRNA, protein, and phosphoprotein levels expression in head and neck cancer patient tissues

Sarah Wheeler, Raja Seethala, Doris Siwak, Kathleen Cieply, Carol Sherer, Gordon Mills, Jennifer R. Grandis, Ann Marie Egloff
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4646.
https://doi.org/10.1158/1538-7445.AM10-4646
Published: 15 April 2010
View article titled, Abstract 4646: Evaluation of EGFR gene amplification status, mRNA, protein, and phosphoprotein levels expression in head and neck cancer patient tissues
Journal Articles

Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition

Olga K. Mirzoeva, Debopriya Das, Laura M. Heiser, Sanchita Bhattacharya, Doris Siwak, Rina Gendelman, Nora Bayani, Nicholas J. Wang, Richard M. Neve, Yinghui Guan, Zhi Hu, Zachary Knight, Heidi S. Feiler, Philippe Gascard, Bahram Parvin, Paul T. Spellman, Kevan M. Shokat, Andrew J. Wyrobek, Mina J. Bissell, Frank McCormick, Wen-Lin Kuo, Gordon B. Mills, Joe W. Gray, W. Michael Korn
Journal: Cancer Research
Cancer Res (2009) 69 (2): 565–572.
https://doi.org/10.1158/0008-5472.CAN-08-3389
Published: 15 January 2009
View article titled, Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
Open the PDF for Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition in another window
Includes: Supplementary data
Journal Articles

Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance

Nathan T. Ihle, Robert Lemos, Jr., Peter Wipf, Adly Yacoub, Clint Mitchell, Doris Siwak, Gordon B. Mills, Paul Dent, D. Lynn Kirkpatrick, Garth Powis
Journal: Cancer Research
Cancer Res (2009) 69 (1): 143–150.
https://doi.org/10.1158/0008-5472.CAN-07-6656
Published: 31 December 2008
View article titled, Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance
Open the PDF for Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance in another window
Journal Articles

Reverse-phase protein array (RPPA) profiling of response to taxanes and epidermal growth factor receptor (EGFR) inhibitors identifies an inverse correlation between markers of sensitivity to docetaxel and erlotinib in non-small cell lung cancer lines

Lauren Averett Byers, Meera Nanjundan, Luc Girard, Kevin Coombes, Yang Xie, Michael Peyton, Sunny Zachariah, Stephanie Weber, Doris Siwak, Petros Nikolinakos, Ignacio Wistuba, Jack Roth, Gordon Mills, John Minna, John Heymach
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3937.
Published: 01 May 2008
View article titled, Reverse-phase protein array (RPPA) profiling of response to taxanes and epidermal growth factor receptor (EGFR) inhibitors identifies an inverse correlation between markers of sensitivity to docetaxel and erlotinib in non-small cell lung cancer lines
Journal Articles

ErbB signaling promotes BCR-Abl expression and modulates multiple signaling pathways as assessed by high-throughput reverse-phase protein array.

Laura Nelson, Doris Siwak, Yiling Lu, Gordon Mills, Claudia Miller, Joya Chandra, Dennis Hughes
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1804.
Published: 01 May 2007
View article titled, ErbB signaling promotes BCR-Abl expression and modulates multiple signaling pathways as assessed by high-throughput reverse-phase protein array.
Journal Articles

Systems-based analysis of responses to stimulation or inhibition of EGF receptor signaling in breast cancer cells

Olga Mirzoeva, Jing Zhang, Richard Neve, Heidi Feiler, Ju Han, Wen-Lin Kuo, Nora Bayani, Zhi Hu, Yinhui Guan, Debopriya Das, Laura Heiser, Doris Siwak, Merrill Knapp, Gordon Mills, Keith Ladaroute, Carolyn Talcott, Bahram Parvin, Paul Spellman, Frank McCormick, Joe Gray, W. Korn
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4427.
Published: 01 May 2007
View article titled, Systems-based analysis of responses to stimulation or inhibition of EGF receptor signaling in breast cancer cells
Journal Articles

Reverse phase protein microarrays is sensitive, stable and quantitative in clinical application

Yiling Lu, Bryan Hennessy, Doris Siwak, Raoul Tibes, Qinghua Yu, Shuangxing Yu, Gordon B. Mills
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 839.
Published: 15 April 2006
View article titled, Reverse phase protein microarrays is sensitive, stable and quantitative in clinical application
Journal Articles

Use of functional proteomics in classification of breast cancer

Bryan T. Hennessy, Yiling Lu, John P. Lahad, Doris Siwak, Raoul Tibes, Ana Gonzalez-Angulo, Gordon B. Mills
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 869.
Published: 01 May 2005
View article titled, Use of functional proteomics in classification of breast cancer